Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

The Company recently completed its previous share repurchase authorization ... visit Civeo's website at www.civeo.com. This news release contains forward-looking statements within the meaning ...

An American woman detained for weeks in Afghanistan by the Taliban has been released from custody, according to a person ...

The job of parenting can be consuming with the drive to protect children in all circumstances, including the unthinkable.

They call him an opportunist and a vulture who’s capitalizing on a tragedy to promote his dangerous Medicare for All agenda.

Blueprint Medicines' strong pipeline and Ayvakit growth make it promising. Read why BPMC stock is rated "Hold" due to high ...

An updated version of the MCP spec introduced key upgrades to make AI agents more secure, capable and interoperable.

A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.

Operator: Good morning and thank you for standing by. Currently, all the participants are in a listen-only mode. After ...

ERP solutions provider Acumatica announced the rollout of its R1 release, sporting enhanced AI features as well as more ...

I Gedeon Richter Plc. announces today that the European Medicines Agency has accepted Richter’s marketing authorization application (MAA) for ...

We are delighted by Ajay’s return to the Board of Invivyd as the company prepares to take the next step forward in scaling the medical benefit from its core technologies. Invivyd has rapidly ...